Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 3, 2001, Pages 531-534

  Arkwright, Peter D ^a   David, Timothy J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Atopic dermatitis; Atopy; Mycobacterium vaccae

Indexed keywords

IMMUNOGLOBULIN E; MYCOBACTERIUM VACCAE VACCINE; UNCLASSIFIED DRUG; VACCINE;

ARTICLE; ATOPIC DERMATITIS; ATOPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM VACCAE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; TH2 CELL; TUBERCULOSIS;

EID: 0035094643     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.113081     Document Type: Article

References (20)

1. The environmental predictors of allergic disease
2. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema
3. Asthma: An epidemic in the absence of infection?
4. The role of lymphocytes in allergic disease
5. The origin and erratic global spread of tuberculosis. How the past explains the present and is the key to the future
6. Long-term trends in tuberculosis. Comparison of age-cohort data between Hong Kong and England and Wales
7. The inverse association between tuberculin responses and atopic disorder
8. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae
9. Effect of pre-immunization by killed Mycobacterium bovis and vaccae on immunoglobulin E response in ovalbumin sensitized newborn mice
10. Randomised trial of intradermal Mycobacterial vaccae or intradermal hepatitis B immunisation in children with HIV infection
11. Six area, six sign atopic dermatitis (SASSAD) severity score: A simple system for monitoring disease activity in atopic dermatitis
12. Low serum zinc in children with atopic dermatitis
13. Early BCG vaccination and development of atopy
14. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria
15. Possible improved survival of patients with stage IV AJCC melanoma receiving SLR 172 immunotherapy: Correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes
16. Immunotherapy of advanced prostate cancer: A phase I/II trial using Mycobacterium vaccae (SLR 172)
17. Epithelial-mesenchymal interactions in the pathogenesis of asthma
18. Dendritic cells: Unique leukocyte populations which control the primary immune response
19. Atopic dermatitis: New insights and opportunities for therapeutic intervention
20. Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells